botensilimab,balstilimab
agenus
agenus shows unprecedented activity for botensilimab/balstilimab combination in microsatellite stable colorectal cancer at esmo world gi congress $agen 
Run by investors, for investors.

Real-time:
PRs
Gov. contract awards
Earnings
M&As
FDA approvals
Insider trades
SEC filings
And more

Not investment advice